Mycophenolate mofetil ameliorates accelerated progressive nephropathy in rat

Kidney and Blood Pressure Research

Volumn 29, Issue 1, 2006, Pages 60-66

  Bloudickova S ^a   Rajnoch, J ^a   Lodererova A ^a   Honsova E ^a   Viklicky O ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Chronic allograft nephropathy; Hypertension; Ischemia reperfusion injury; Mycophenolate mofetil; Transgenic rat

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLAMP; CONTROLLED STUDY; FEEDING; GLOMERULOSCLEROSIS; HYPERTENSION; IMMUNITY; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY DISEASE; KIDNEY FUNCTION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MONOCYTE; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; SYSTOLIC BLOOD PRESSURE; TRANSGENIC ANIMAL; UNINEPHRECTOMY;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HYPERTENSION, RENAL; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MYCOPHENOLIC ACID; RATS; REPERFUSION INJURY;

EID: 33745016299     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092948     Document Type: Article

References (22)

1. De Greef KE, Ysebaert DK, Vercauteren SR, Chapelle T, Roeyen G, Bosmans JL, Verpooten GA, De Broe ME: Effect of immunosuppression on damage, leukocyte infiltration and regeneration after severe warm ischemia/reperfusion renal injury. Transplant Proc 2002;34:791-794.
2. Noris M, Azzollini N, Pezzotta A, Mister M, Benigni A, Marchetti G, Gagliardini E, Perico N, Remuzzi G: Combined treatment with mycophenolate mofetil and an angiotensin II receptor antagonist fully protects from chronic rejection in a rat model of renal allograft. J Am Soc Nephrol 2001;12:1937-1946.
3. Viklický O, Bohmová R, Ouyang N, Honsová E, Lodererová A, Mandys V, Vítko Š, Lutz J, Heemann UW: Effect of sirolimus on renal ischemia/reperfusion injury in normotensive and hypertensive rats. Transpl Int 2004;17:432-441.
4. Viklický O, Zou H, Muller V, Lácha J, Szabó A, Heemann U: SDZ-RAD prevents manifestation of chronic rejection in rat renal allografts. Transplantation 2000;69:497-502.
5. Viklický O, Muller V, Zou H, Szabó A, Vítko Š, Heemann U: RAD reduces compensatory renal graft hypertrophy in a rat model of chronic rejection. Transplant Proc 2001;33:2320-2321.
6. Jolicoeur EM, Qi S, Xu D, Dumont L, Daloze P, Chen H: Combination therapy of mycophenolate mofetil and rapamycin in prevention of chronic renal allograft rejection in the rat. Transplantation 2003;75:54-59.
7. Gregory CR, Huang X, Pratt RE, Dzau VJ, Shorthouse R, Billingham ME, Morris RE: Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. Transplantation 1995;59:655-661.
8. 1 in chronic cyclosporine nephrotoxicity. Am J Transplant 2003;3:1550-1559.
9. Saurina A, Campistol JM, Piera C, Diekmann F, Campos B, Campos N, de Las Cuevas X, Oppenheimer F. Conversion from calcineurin inhibitors to sirolimus in chronic allograft dysfunction: changes in glomerular haemodynamics and proteinuria. Nephrol Dial Transplant 2005;Nov 9 (online doi:10.1093/ndt/gfi266).
10. Nankivell BJ, Borrows RJ, Fung CLS, O'Connell PJ, Allen RDM, Chapman JR: The natural history of chronic allograft nephropathy. N Engl J Med 2003;349:2326-2333.
11. Baboolal K, Jones GA, Janezic A, Griffiths DR, Jurewicz WA. Molecular and structural consequences of early renal allograft injury. Kidney Int 2002;61:686-696.
12. Rodríguez-Iturbe B, Quiroz Y, Nava M, Bonet L, Chávez M, Herrera-Acosta J, Johnson RJ, Pons HA: Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol 2002;282:191-201.
13. Muller DN, Shagdarsuren E, Park JK, Dechend R, Mervaala E, Hampich F, Fiebeler A, Ju X, Finckenberg P, Theuer J, Viedt C, Kreuzer J, Heidecke H, Haller H, Zenke M, Luft FC: Immunosuppressive treatment protects against angiotensin II-induced renal damage. Am J Pathol 2002;161:1679-1693.
14. Ventura CG, Coimbra TM, de Campos SB, de Castro I, Yu L, Seguro AC: Mycophenolate mofetil attenuates renal ischemia/reperfusion injury. J Am Soc Nephrol 2002;13:2524-2533.
15. Rodríguez-Iturbe B, Pons HA, Quiroz Y, Gordon K, Rincón J, Chávez M, Parra G, Herrera-Acosta J, Gómez-Garre D, Largo R, Egido J, Johnson RJ: Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int 2001;59:2222-2232.
16. Badid C, Vincent M, McGregor B, Melin M, Hadj-Aissa A, Veysseyre C, Hartmann DJ, Desmouliere A, Laville M: Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney. Kidney Int 2000;58:51-61.
17. Hause IA, Renders L, Radeke HH, Sterzel RB, Goppelt-Sttruebe M: Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion. Nephrol Dial Transplant 1999;14:58-63.
18. Flechner SM, Kurian SM, Solez K, Cook DJ, Burke JT, Rollin H, Hammond JA, Whisenant T, Lanigan CM, Head SR, Salomon DR: De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years. Am J Transplant 2004;4:1776-1785.
19. Muller V, Hamar P, Szabo A, Knust E, Vogelsgang M, Heemann U: Effect of mycophenolate mofetil on the in vivo infiltration of lymphocytes in the rat remnant kidney. Transplant Proc 1998;30:982.
20. Heemann U, Azuma H, Hamar P, Schmid C, Tilney N, Philipp T: Mycophenolate mofetil inhibits lymphocyte binding and the upregulation of adhesion molecules in acute rejection of rat kidney allografts. Transplant Immunol 1996;4:64-67.
21. Abbate M, Zoja C, Corna D, Capitanio M, Bertani T, Remuzzi G: In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation. J Am Soc Nephrol 1998;9:1213-1224.
22. Remuzzi G, Zoja C, Gagliardini E, Corna D, Abbate M, Benigni A: Combining an antiproteinuric approach with mycophenolate mofetil fully suppresses progressive nephropathy of experimental animals. J Am Soc Nephrol 1999;10:1542-1549.